Entity Common Stock, Shares Outstanding of ABEONA THERAPEUTICS INC. from 12 Aug 2011 to 11 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ABEONA THERAPEUTICS INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Aug 2011 to 11 Mar 2026.
  • ABEONA THERAPEUTICS INC. Entity Common Stock, Shares Outstanding for the quarter ending 11 Mar 2026 was 57,049,023, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ABEONA THERAPEUTICS INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 57,049,023 +8,515,225 +18% 11 Mar 2026 10-K 17 Mar 2026 2025 FY
Q3 2025 54,191,361 +10,720,331 +25% 07 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 51,278,539 +7,964,142 +18% 08 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 48,533,798 +21,178,761 +77% 11 Mar 2025 10-K 20 Mar 2025 2024 FY
Q3 2024 43,471,030 +18,697,713 +75% 12 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 43,314,397 +18,558,524 +75% 02 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 27,355,037 +9,646,069 +54% 06 Mar 2024 10-K 18 Mar 2024 2023 FY
Q3 2023 24,773,317 +7,597,518 +44% 01 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 24,755,873 +18,805,491 +316% 01 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 17,708,968 -129,669,054 -88% 21 Mar 2023 10-K/A 10 Apr 2023 2022 FY
Q3 2022 17,175,799 -84,742,115 -83% 07 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 5,950,382 -95,276,632 -94% 01 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 147,378,022 +48,589,089 +49% 21 Mar 2022 10-K 31 Mar 2022 2021 FY
Q3 2021 101,917,914 +3,390,191 +3.4% 08 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 101,227,014 +16,449,273 +19% 21 Jul 2021 10-Q 28 Jul 2021 2021 Q2
Q1 2021 98,788,933 +15,166,798 +18% 19 Mar 2021 10-K 24 Mar 2021 2020 FY
Q3 2020 98,527,723 +47,373,328 +93% 02 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 84,777,741 +35,461,990 +72% 03 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 83,622,135 +35,672,441 +74% 09 Mar 2020 10-K 16 Mar 2020 2019 FY
Q3 2019 51,154,395 +3,209,909 +6.7% 07 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 49,315,751 +1,372,466 +2.9% 05 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 47,949,694 +722,754 +1.5% 13 Mar 2019 10-K 18 Mar 2019 2018 FY
Q3 2018 47,944,486 +1,169,229 +2.5% 09 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 47,943,285 +7,656,026 +19% 09 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 47,226,940 +6,971,858 +17% 15 Mar 2018 10-K 16 Mar 2018 2017 FY
Q3 2017 46,775,257 +6,815,689 +17% 13 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 40,287,259 +7,491,556 +23% 11 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 40,255,082 +7,512,069 +23% 30 Mar 2017 10-K 30 Mar 2017 2016 FY
Q3 2016 39,959,568 14 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 32,795,703 +105,097 +0.32% 16 May 2016 10-Q 16 May 2016 2016 Q1
Q1 2016 32,743,013 +12,754,212 +64% 30 Mar 2016 10-K 30 Mar 2016 2015 FY
Q4 2015 32,732,783 16 Nov 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 32,690,606 14 Aug 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 19,988,801 30 Mar 2015 10-K 31 Mar 2015 2014 FY
Q2 2012 24,172,877 +12,571,472 +108% 14 Aug 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 20,264,551 23 Mar 2012 10-K 23 Mar 2012 2011 FY
Q3 2011 23,170,774 11 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 11,601,405 12 Aug 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.